WVE Q3 2018 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+564.6% YoY

Gross Profit

-$28M-631.7% margin

Operating Income

-$38M-850.9% margin

Net Income

-$38M-837.5% margin

EPS (Diluted)

$-1.28

QoQ Revenue Growth

-7.9%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$32M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$325M

Total Liabilities

$218M

Stockholders' Equity

$107M

Cash & Equivalents

$210M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$676,000	+564.6%
Gross Profit	-$28M	-$19M	-46.1%
Operating Income	-$38M	-$27M	-41.6%
Net Income	-$38M	-$26M	-44.0%